Last reviewed · How we verify
NCT05270967: fdg
FDG (Fluorodeoxyglucose) Findings After COVID-19 Vaccination
trial testing F-18 FDG PET/CT imaging in Vaccine Reaction in 129 participants. Completed in 10 January 2022.
10 January 2022
Quick facts
| Lead sponsor | Kocaeli University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 129 |
| Start date | 29 July 2021 |
| Primary completion | 10 January 2022 |
| Estimated completion | 10 January 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- F-18 FDG PET/CT imaging
- Pfizer/biontech mRNA vaccine — full drug profile →
Conditions studied
- Vaccine Reaction — all drugs for Vaccine Reaction →
- Oncology — all drugs for Oncology →
Sponsor
Kocaeli University
Who can join
18 and older, any sex, with Vaccine Reaction or Oncology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is important to evaluate the vaccine-related metabolic changes on FDG PET/CT to avoid confusing results. The investigators aimed to assess the frequency and intensity of regional and systemic metabolic PET/CT changes of patients who received the mRNA-based COVID-19 vaccine (BNT162b2-Pfizer/BioNTech) and to analyze possible factors affecting these changes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05270967
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vaccine Reaction
Currently open trials in the same condition.
- NCT05825651 — Long COVID and Its Associations With Health Outcomes in Older Adults · active not recruiting
- NCT06286488 — Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza · Phase 4 · active not recruiting
Other Kocaeli University trials
Trials by the same sponsor.
- NCT06737887 — The Effect of Preoperative Stoma Simulation on Anxiety and Postoperative Adaptation · NA · recruiting
- NCT07483593 — Baseline Gastric Volume in Diabetic vs Non-Diabetic Patients · not yet recruiting
- NCT07536659 — Evaluation of Serum Autophagic Biomarkers in the Acute Response to Walking and Cycling in Healthy Male Individuals · enrolling by invitation
- NCT07482696 — Electromyographic Biofeedback Therapy in Patients With Dyssynergic Defecation · NA · not yet recruiting
- NCT07497945 — Optic Nerve Sheath Diameter for Predicting Post-Dural Puncture Headache in Cesarean Section Patients · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05270967 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kocaeli University
- Last refreshed: 8 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05270967.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing